CANNIMED SIGNS LETTER OF INTENT WITH PHARMASAVE Apr 4th 2018 TSX: ACB TSX: CMED
EDMONTON and SASKATOON, April 4, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc. ("CanniMed") (TSX: CMED) announced today that CanniMed has entered into a Letter of Intent to become a preferred supplier of medical cannabis to Pharmasave. A member governed cooperative of more than 650 independently owned community pharmacies across the country, Pharmasave is one of Canada's leading independent community pharmacies.
Subject to changes to regulations that would allow such distribution, CanniMed and Aurora will supply and distribute high-quality medical cannabis, produced at the companies' GMP compliant and GMP certified facilities, through Pharmasave pharmacists across Canada.
..."Aurora is close to completion of the acquisition... of all the outstanding shares of CanniMed Therapeutics Inc, Canada's most experienced licensed producer of medical cannabis, adding over 20,000 kg per annum in funded capacity, as well as Canada's strongest medical cannabis brand."... https://investor.auroramj.com/press-releases/
..."The compulsory acquisition is expected to be completed...... shortly after April 30, 2018. Intermediaries on behalf of beneficial holders will receive a notice from CDS."https://ca.advfn.com/p.php?pid=nmona&article=77172076